Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 1 5Phase NA 3Phase 2/3 1

Status

Completed 5

Sponsor Class

NIH 4OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 5

Conditions

Prostatic Neoplasms 5Prostatic Intraepithelial Neoplasia 1Neoplasm Metastasis 1

Interventions

Docetaxel 43enzalutamide 31Prednisone 25Abiraterone Acetate 24Magnetic Resonance Spectroscopy 18abiraterone 15pembrolizumab 14bicalutamide 14Radiotherapy 14Cyclophosphamide 13darolutamide 12Leuprolide 12Goserelin 12apalutamide 10Ipilimumab 10olaparib 9Specimen Handling 9Radiosurgery 9Radiation 9Injections 9Biopsy 9Pluvicto 8Paclitaxel 8Radiotherapy, Intensity-Modulated 7Carboplatin 7sargramostim 6fludarabine 6cabazitaxel 6Sirolimus 6Nivolumab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1 × Prostatic Neoplasms × Lycopene × Clear all
NCT01949519 2018-01-11

Docetaxel and Lycopene in Metastatic Prostate Cancer

Medical University of South Carolina

Phase 1 Completed
24 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT00450957 2015-04-15

Lycopene in Healthy Male Participants

National Cancer Institute (NCI)

Phase 1 Completed
20 enrolled
Genitourinary

Prostatic Neoplasms

NCT00006078 2013-06-26

Lycopene In Preventing of Prostate Cancer

National Cancer Institute (NCI)

Phase 1 Completed
Genitourinary

Prostatic Neoplasms

NCT00093561 2013-06-26

Lycopene in Preventing Prostate Cancer in Healthy Participants

National Cancer Institute (NCI)

Phase 1 Completed
Genitourinary

Prostatic Neoplasms

NCT00416325 2013-06-26

Lycopene in Preventing Prostate Cancer in Patients Who Are at High Risk of Developing Prostate Cancer

National Cancer Institute (NCI)

Phase 1 Completed
18 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡